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Background: Delirium is common, associated with poor outcome, but its pathophysiology remains obscure. The
aim of the present study was to study a possible role of monocyte chemoattractant protein-1 (MCP-1) in the
development of delirium.
Findings: A prospective cohort of 19 hip fracture patients (median age 83 years) were screened for delirium daily
by validated methods. MCP-1 was measured on arrival and postoperatively. The number of patients with a raise in
MCP-1 was statistically significantly higher in the group with delirium in the postoperative phase compared to the
no-delirium group (5/6 vs. 1/7, p = .03).
Conclusions: MCP-1 might play a role in the development of delirium.
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Delirium (“acute confusional state”), defined as an acute
and fluctuating change in consciousness and cognition,
is a common condition associated with poor outcome
[1]. Despite its common occurrence, the pathophysiology
of delirium remains poorly understood. A number of mech-
anisms have been proposed, mainly emphasizing neuro-
transmission, inflammation, and chronic stress [2-4].
Monocyte chemoattractant protein-1 (MCP-1) is a che-
mokine that attracts leukocytes of the monocyte lineage [5].
Within the CNS, MCP-1 is produced mainly by astrocytes
and resident microglia, and MCP-1 overexpression has
been associated with neuroinflammatory conditions like
multiple sclerosis, stroke and Alzheimer’s disease [6].
MCP-1 is constitutively expressed by both glial cells and
neurons, suggesting a possible neuromodulating func-
tion [7] and has been shown to increase cell excitability
and dopamine release in dopaminergic neurons in rat
substantia nigra [8]. Since both neuroinflammation and
neurotransmitter disturbances, especially acetylcholine
deficiency and dopamine excess, have been proposed as* Correspondence: t.b.wyller@medisin.uio.no
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unless otherwise stated.pathophysiological mechanisms in delirium [9,10], we
hypothesized a role of MCP-1 in the pathogenesis. To
our knowledge, the role of MCP-1 in delirium has only
been studied in ICU patients, showing a significant as-
sociation between MCP-1 and delirium in patients with
systemic inflammatory response syndrome (SIRS) [11].
The aim of the current study was thus to investigate the
relationship between MCP-1, measured in serum pre-
operatively and postoperatively, and the development of
delirium in a population of elderly hip fracture patients.Methods
This is a substudy of a prospective study designed to
evaluate risk factors for preoperative and postoperative
delirium in elderly hip fracture patients [12]. Patients
aged ≥ 65, acutely admitted for a hip fracture, who spoke
Norwegian, had no severe aphasia, head injury or ter-
minal illness, and were admitted for at least 48 hours,
were eligible. Patients admitted to Oslo University Hos-
pital or Diakonhjemmet Hospital, Oslo, Norway, in the
period from May through December 2006, providing a
written informed consent and from whom at least one
blood sample was drawn, were included in the current
study.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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laration of Helsinki and approved by the Eastern Norway
Regional Committee for Ethics in Medical Research
(Project # 05075) and Ullevaal University Hospital Data
Protection Officer. The patients were observed for a
minimum of 48 hours and a maximum of 5 days after
the operation.
Patients were screened for delirium within 48 hours of
admission, thereafter on a daily basis (weekdays) until
discharge or the fifth postoperative day. Delirium was di-
agnosed using the Confusion Assessment Method (CAM)
criteria [13]: change in mental status with acute onset
and/or fluctuating course, inattention, and disorganized
thinking or altered level of consciousness. Details on the
procedure have been published [12].
Pre-fracture cognitive function was determined using
the short form of the Informant Questionnaire on Cog-
nitive Decline in the Elderly (IQCODE), and patients
with IQCODE scores 3.44 or greater were considered as
probably suffering from pre-fracture cognitive decline
[14]. The patients’ overall physical health was assessed
according to the American Society of Anesthesiologists
(ASA) score. The Barthel Index (maximum score 20)
was scored by a close caregiver to give an indication of
pre-fracture functioning in activities of daily living [15].
Blood samples were collected preoperatively and post-
operatively, centrifuged at 3500 rpm for 10 minutes andTable 1 Participants in the study
Patient Preoperative delirium Postoperative delirium Barthel ASA
1 Yes Yes 8 3
2 No No 20 2
3 No Yes 19 2
4 No No 20 2
5 No Yes - 2
6 No No 20 2
7 Yes Yes 16 3
8 Yes Yes 16 2
9 No No 19 2
10 Yes Yes 19 2
11 Yes Yes - 2
12 No No 20 2
13 - Yes 18 2
14 - No 20 2
15 - Yes 20 2
16 - No 20 3
17 - No 20 2
18 - No 17 2
19 - No - 2
Barthel: Barthel Activity of Daily Living Score. ASA: American Society of Anesthesiolo
Elderly. MCP: Monocyte chemoattractant protein.stored at-70C. MCP-1 was measured by an enzyme-
linked immunosorbent assay (ELISA) method with com-
mercially available kits (R & D Systems Europe, Abingdon,
Oxon, UK). To minimize run-to-run variability, serial sam-
ples from the same individuals were analyzed in the same
microtiter run. In our laboratory the inter-assay coefficient
of variation for MCP-1 was 9.2%.
Mann–Whitney U test was conducted to compare
levels of MCP-1 markers in patients with and without
delirium. For change in MCP-1 concentration, we had
to dichotomize the variable (raise versus steady state
or fall) and use the chi-square test as the distribution
was not homoscedastic, and the conditions for using
the Mann–Whitney U test thus not fulfilled [16]. For
this analysis, every raise in the concentration (above
zero) was defined as a raise.
Findings
Preoperative blood samples were collected from 19 pa-
tients with median (interquartile range) age 83 (79–91)
years (Table 1). 14 (74%) were women, 3 (16%) had ASA
score >2, 5/16 (31%) had an IQCODE score > 3.44, and
5/16 (31%) had a premorbid Barthel Index score ≤ 18.
All had at least three days of postoperative delirium
assessments.
Twelve of the patients were screened for delirium pre-
operatively and 5 of them were found to be delirious atIQCODE MCP1 preoperatively pg/mL MCP1 postoperatively pg/mL
5.00 274 -
2.94 308 -
4.31 298 -
3.00 430 -
- 515 -
3.06 334 -
4.88 879 424
4.81 237 318
3.06 372 350
3.12 356 509
- 255 521
3.00 303 260
4.81 255 521
3.06 334 485
3.13 265 673
3.00 384 334
3.00 284 274
3.00 778 650
- 473 329
gists score. IQCODE: Informant Questionnaire on Cognitive Decline in the
Figure 1 Boxplot of the change in serum concentration of monocyte chemoattractant protein-1 (MCP-1) from the preoperative to the postoperative
phase by postoperative delirium status. n = 13.
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in MCP-1 concentration between patients with and
without preoperative delirium (median 274 and 334 pg/
mL, respectively, p = 0.29, Mann–Whitney test).
In 13 of the 19 patients screened for delirium postop-
eratively, blood samples were collected both preopera-
tively and postoperatively (Table 1). Of these 13, 6 were
delirious in the postoperative phase (regardless of time
of onset), whereas 7 remained lucid throughout the stay.
Five of 6 of patients with postoperative delirium and 1
of 7 without postoperative delirium had a rise in MCP-1
from the preoperative to the postoperative phase (p = 0.03,
chi-square test). The median change from preoperative to
postoperative measurement was 210 pg/mL in those with
(n = 6), and-43 pg/mL in those without (n = 7) postopera-
tive delirium (Figure 1).
Discussion
A raise in MCP-1 was associated with postoperative de-
lirium. The observation accords well with a hypothesis
linking neuroinflammation, acetylcholine deficiency and
dopamine excess to the pathophysiology of delirium [9].
Our findings are in line with the only other study that
has measured MCP-1 in delirium [11]. That study also
found that the serum levels of the pro-inflammatory cy-
tokines IL-6 and IL-8 were higher in patients with delir-
ium. The same cytokines have been reported to be
higher in delirium also in other studies, both in serum
[17,18] and in CSF [19]. A recently published study
comprising 43 hip fracture patients found that CSF
levels of IL-1ß was higher in patients with delirium, a
finding that gives further support to a theory thatinflammatory mechanisms are at play in the pathophysi-
ology of delirium [20].
Support of increased inflammatory activity in the brain
in delirium also come from a postmortem study were brain
autopsies were performed within 24 hours after death in
nine patients with delirium and six age-matched controls.
In patients with delirium markers of microglial activity
(HLA-DR and CD 68), astrocyte activity (GFAP) and IL-6
were increased [21].
Strengths of our study are its prospective design with
comprehensive serial clinical evaluations, and the high
sensitivity and specificity and low inter-assay coefficient
of variation of the laboratory assay. Main limitations in-
clude the low number of patients, the fact that the time
of collecting the blood samples was not standardized ac-
cording to the time of surgery, and that the analyses are
not accounting for diurnal or other physiological MCP-1
fluctuations in peripheral blood. The limited sample size
provided insufficient power as to adjust for potential
confounding factors by multivariate analysis. Since
knowledge on delirium pathophysiology is rather scarce,
we assume that the observation may be of interest, and
give rise to more refined hypotheses that can be con-
firmed or rejected in larger studies.
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